Evidence map›Paper›PMID 41428089›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2026

The role of comorbidities on periprocedural complications and outcomes in patients with defibrillators and cardiac resynchronization therapy: insights from the German device registry.

Nina Becher, Matthias Hochadel, Jochen Senges, Lars Eckardt, Hüseyin Ince, Thomas Kleemann, Christoph Stellbrink, Johannes Brachmann, Werner Jung, Frederik Voss and 3 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nina BecherDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. n.becher@uke.de.ORCID http://orcid.org/0000-0002-4476-1341
Matthias HochadelStiftung Institut Fuer Herzinfarktforschung (IHF), Ludwigshafen, Germany.ORCID http://orcid.org/0000-0003-0499-704X
Jochen SengesStiftung Institut Fuer Herzinfarktforschung (IHF), Ludwigshafen, Germany.ORCID http://orcid.org/0009-0001-3547-2126
Lars EckardtClinic for Cardiology II - Electrophysiology, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-3735-8503
Hüseyin InceDepartment of Cardiology, Vivantes Klinikum Am Urban and Neukölln, Berlin, Germany.
Thomas KleemannMedizinische Klinik B, Klinikum Der Stadt Ludwigshafen gGmbH, Ludwigshafen Am Rhein, Germany.
Christoph StellbrinkDepartment of Cardiology, Klinikum Bielefeld Mitte, Bielefeld, Germany.ORCID http://orcid.org/0000-0002-8429-2826
Johannes BrachmannDepartment of Cardiology, Klinikum Coburg, Coburg, Germany.ORCID http://orcid.org/0000-0002-9221-9856
Werner JungDepartment of Cardiology, Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany.ORCID http://orcid.org/0009-0005-1320-8091
Frederik VossInnere Medizin III, Krankenhaus Der Barmherzigen Brüder, Trier, Germany.ORCID http://orcid.org/0009-0002-5372-9228
Paulus KirchhofDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-1881-0197
Tobias ToennisDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-7351-0621
Andreas MetznerDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-6818-6396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac implantable electronic devices (CIEDs) are increasingly implanted in older patients with multiple comorbidities. The impact of comorbidities on procedural complications and clinical outcomes during and after defibrillator implantation remains a subject of ongoing debate.

aimTo investigate the associations of the comorbidity burden on baseline characteristics, periprocedural complications, and on outcomes in patients with implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy with defibrillator (CRT-D) implantations or revisions.

methodsPatients who underwent ICD or CRT-D implantations or revisions at 50 centers were prospectively enrolled in the German Device Registry. Data on patient characteristics, periprocedural complications, and outcomes were collected. Patients were categorized into four groups based on cardiometabolic comorbidities (stroke, chronic kidney disease (CKD), diabetes, hypertension): group I (no comorbidities), group II (one), group III (two), and group IV (three or four). Primary outcomes included 1-year all-cause mortality, major adverse cardiac and cerebrovascular events (MACCE), and arrhythmic/non-arrhythmic events. The Kaplan-Meier analysis was used to determine 1-year mortality.

resultsOverall, 5329 patients (mean age 65.2 years) underwent 3794 ICD and 1535 CRT-D implantations. Median follow-up was 17 months. Periprocedural complications (group I: 2.1%, group II: 1.5%, group III: 2.1%, group IV: 2.4%; p = 0.91) and in-hospital MACCE (group I: 0.2%, group II: 0.4%, group III: 0.6%, group IV: 0.4%; p = 0.25) were not related to comorbidity burden. Higher comorbidity burden was associated with a higher 1-year all-cause mortality (p < 0.001), but ICD shocks did not differ between groups (p = 0.97). The MADIT-ICD non-arrhythmic mortality score increased with comorbidities (p < 0.001), while the VT/VF score remained unchanged.

conclusionsPeriprocedural complications do not appear to be affected by cardiometabolic comorbidities in patients undergoing ICD or CRT-D implantation in Germany. As expected, multimorbidity was associated with a higher risk of mortality and MACCE without detectable effects on ventricular arrhythmias.

Indexed as

Cardiac Resynchronization TherapyDefibrillators, ImplantablePostoperative ComplicationsRegistriesAgedAged, 80 and overComorbidityFemaleFollow-Up StudiesGermanyHumansMaleMiddle AgedProspective StudiesRisk FactorsTime FactorsComorbiditiesComorbidity burdenImplantable cardioverter-defibrillatorMortality

Identifiers

PMID41428089
PMCPMC13013360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.